#OpenAccess | Geriatric assessment has been considered the standard of care to avoid the risk of over- or under-treatment and minimize the risk of adopting an ageist approach. 🔗 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Cristiane D Bergerot, PhD, FASCO Paulo G Bergerot Enrique Soto William Dale, MD, PhD, FASCO

Getting ready to present the “Viray-CGA” a cancer specific comprehensive geriatric assessment “The Viray Way” 🤓 #geriatrics #oncology #gerionc #ANZSGM Young SIOG

An honour to listen to Kenneth Rockwood Prof Kenneth Rockwood, of the Rockwood Clinical Frailty Scale infamy speaking at the plenary session of #ANZSGM2023

Paul Viray welcome to Twitter! Here’s the Position Statement you led! Congratulations! 🎉📚

What a dream to share my “Viray-CGA” (my cancer-specific CGA for pragmatic use in an Australian setting) with international geriatrics legend Prof Rockwood Kenneth Rockwood #gerionc #geriatrics #oncology #ANZSGM2023 Young SIOG

CGA has a NNT = 9 for admission avoidance and 30 for avoiding long term care; but also 8 for avoidance of treatment toxicity for patients with cancer. A signal CGA can be used effectively across healthcare pathways. #BGSconf

The power of a Comprehensive Geriatric Assessment for older adult patients in any setting including cancer

If anyone has difficulty accessing the link to the Australia & New Zealand Society of Geriatric Medicine (#ANZSGM) position statement I led… private message me 🤓 keep an eye out for the “Viray-CGA” I shall be promoting and teaching as part of “The Viray Way”…

Very interesting data presented by Dr Alibhai regarding the potential cost effectiveness of geriatric assessment for older adults receiving curative cancer chemotherapy. #gerionc

Together we can try and break these barriers #gerionc #oncogeris COSA ANZSGM

As I continue my dual training in oncology and geriatric medicine in Australia, it is evident the many barriers but also enablers to this. We must not stop trying COSA ANZSGM

The reason I am dual specialising in medical oncology and geriatric medicine 🥰🤓 💪 #oncogeris #gerionc COSA ANZSGM

Excellent review of Geri-Onc updates from ASCO 2023 #gerionc #oncogeris ANZSGM COSA

#gerionc #oncogeris COSA ANZSGM

The #G8screening tool and #VES13 tool are officially on Australia’s quintessential oncology resource: eviQ.org.au 🥰 #gerionc #oncogeris COSA ANZSGM informs who would benefit from a CGA, and independently predicts poorer outcomes in older adults with cancer

Love this! Translatable to the Australian setting #gerionc #oncogeris COSA ANZSGM

A low G8 score is associated with mortality if commencing anticancer therapies in older adults with cancer. The G8 score is available on eviq.org.au “assessments” tab and needs to be utilised in oncology! #cosa2024 #gerionc #oncogeris COSA ANZSGM

Geriatric Assessment: ASCO Global Guideline | JCO Global Oncology ascopubs.org/doi/full/10.12…

I’ll be speaking at the PCPA Cancer Summit this Saturday talking about my passion Geriatric Oncology- beyond ECOG, and introducing the Optimal Care Pathway for Older Adults with Cancer in Australia

#NewProfilePic